Author:
Hijane Karima,Nelson Lawrence M.
Abstract
Overt Primary Ovarian Insufficiency (POI) is a rare disorder characterized by a constellation of other rare conditions, posing significant diagnostic and management challenges. This disorder necessitates a global mechanism for information exchange, streamlined data sharing, dynamic international partnerships, and the integration of artificial intelligence to enhance diagnostic accuracy through next-generation sequencing and specific antibody testing. Empowering women with POI involves providing them with access to the best available evidence at the point of care and facilitating informed decisions throughout their health journey. A key strategy is transcending the traditional biomedical model by adopting a population-based approach that encourages global cross-sectional collaboration. Optimal care for women with POI is achieved through an integrated, multidisciplinary approach that leverages diverse expertise to evaluate evidence and update care practices effectively. Initiatives are also underway to establish a patient advocacy group, emphasizing the importance of early diagnosis in allowing women to adapt family planning or preserve fertility. The overarching vision for POI research and care aims to cultivate proactive international partnerships and data sharing, driven by the needs and experiences of women with Overt POI.
Publisher
Global Science Publishing Pty. Lte.
Reference36 articles.
1. Sopiarz, N.; Sparzak, P.B. Primary Ovarian Insufficiency. In StatPearl; Treasure Island (FL): StatPearls Publishing: Amsterdam, The Netherlands, 2024. Available on: https://www.ncbi.nlm.nih.gov/books/NBK589674/ (accessed on 6 March 2023).
2. Stuenkel, C.A.; Gompel, A. Primary Ovarian Insufficiency. New England Journal of Medicine, 2023, 388(2): 154–163. PMID: 36630623. https://doi.org/10.1056/NEJMcp2116488. PMID: 36630623.
3. Taruscio, D.; Gahl, W.A. Rare diseases: Challenges and opportunities for research and public health. Nature Reviews Disease Primers, 2024, 10(1): 13. PMID: 38424095. https://doi.org/10.1038/s41572-024-00505-1.
4. Nguengang Wakap, S.; Lambert, D.M.; Olry, A.; Rodwell, C.; Gueydan, C.; Lanneau, V.; Murphy, D.; Le Cam, Y.; Rath, A. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. European Journal of Human Genetics, 2020, 28(2): 165–173. PMID: 31527858; PMCID: PMC6974615. https://doi.org/10.1038/s41431-019-0508-0.
5. Gibbs, R. A. (2020). The Human Genome Project changed everything. Nature Reviews Genetics, 21(10), 575- 576. https://doi.org/10.1038/s41576-020-0275-3
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献